Adverse metabolic and cardiovascular consequences of circadian misalignment

Frank A. J. L. Scheer(Brigham and Women's Hospital), Steven A. Shea(Oregon Health & Science University), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Michael F. Hilton(Harvard University)

Proceedings of the National Academy of Sciences

March 2, 2009

10.1073/pnas.0808180106

Cited by 2,300

Related Papers

Role of leptin in the neuroendocrine response to fasting

|Nature|1996|3.1k

Obesity and cancer risk: Emerging biological mechanisms and perspectives

|Metabolism|2018|1.6k

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

|Metabolism|2018|1.2k

FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise

|Metabolism|2012|1k

A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on

|Metabolism|2022|1k